Keeping Current Podcast
1) The Alarming Carbon Footprint of Respiratory Disease: The Future of Sustainable Inhaler Technology
Low-carbon inhalers: Are you finding the right balance for optimal patient care and planetary health? Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosur...Show More
2) Achieving Brain Health in Epilepsy: What Can Clinicians Do?
Are you asking about sleep, activity levels, and mood? Why you should be and what to do next. Credit available for this activity expires: 12/31/26 Earn Credit / Learning Objectives & Disclosures: http...Show More
3) Patient Case Challenge: How Would You Manage This Patient With MASH?
Discover the patients who need timely treatment for metabolic dysfunction–associated steatohepatitis (MASH). How will you find them? And then what will you do? Credit available for this activity expir...Show More
4) Navigating the Challenges of IgAN Management: Clinical Implications of Emerging B-Cell Therapies
Alarming in immunoglobulin A nephropathy (IgAN): over 40% present late. Explore latest advancements in management of the most common cause of primary glomerulonephritis worldwide. Credit available for...Show More
5) Person-Centered Care in EGFR-Mutated Advanced NSCLC: Optimizing Outcomes and Experiences
How well are you managing patients on EGFR inhibitor therapies in your clinical practice? Credit available for this activity expires: 12/18/26 Earn Credit / Learning Objectives & Disclosures: https:/...Show More
6) Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy
Learn from the experts about selecting the right BTK inhibitor therapy for patients with chronic lymphocytic leukaemia (CLL) in UK clinical practice. Credit available for this activity expires: 12/16/...Show More
Charting the Course in CLL: A Clinician's Compass for BTK Inhibitor Therapy
34:08 | Dec 18th, 2025
7) How Are ADCs Shaping the Future of Early Breast Cancer Care? Latest Insights and Emerging Strategies
Did you know that, while well established in the metastatic setting, second-generation antibody-drug conjugates are now moving into the early setting? Credit available for this activity expires: 12/10...Show More
8) Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies
Join the program for an in-depth discussion on low-grade glioma – from burden and diagnosis to therapies. Credit available for this activity expires: 12/10/26 Earn Credit / Learning Objectives & Discl...Show More
Pediatric Low-Grade Glioma With BRAF Alterations: Stories, Science, and Strategies
38:04 | Dec 10th, 2025
9) Hot Topics from Berlin 2025: What Experts Say About the Future of Metastatic Breast Cancer Care
Join this program for relevant updates across the advanced and metastatic breast cancer (mBC) spectrum as presented in October 2025. Credit available for this activity expires: 12/8/26 Earn Credit / L...Show More
10) How Are Oral SERDs Changing the Management of Advanced HR-Positive Breast Cancer?
Where do oral selective estrogen receptor degraders (SERDs) fit in the overall landscape of first- and second-line advanced/metastatic breast cancer? Credit available for this activity expires: 12/04/...Show More